Compare Immunovant Inc. Common Stock (IMVT) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Onto Innovation — how do they compare? Immunovant Inc. Common Stock trades at $30.41 (market cap $6.25B), while Onto Innovation trades at $295.49 (market cap $14.36B). The key difference: Onto Innovation is far larger — about 2.3× Immunovant Inc. Common Stock's market cap, and Onto Innovation is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Onto Innovation for 5 Days on average.
| IMVT | ONTO | |
|---|---|---|
Market Cap | $6.25B | $14.36B |
Volume | 1,755,411 | 761,617 |
Sector | Health | Technology |
52-Week High | $44.96 | $378.45 |
52-Week Low | $17.03 | $121.34 |
Typical Hold Time | 1 Days | 5 Days |
Enterprise Value | $5.35B | $13.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
